Pharmaeconomica

Foundation date

February 2023

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

Pharmaeconomica utilizes state-of-the-art computational techniques and a data-driven approach to streamline the drug discovery process. We excel in the pivotal stages of hit identification and hit-to-lead optimization. This is where science meets innovation, as we harness the potential of promising molecular structures and transform them into exceptional drug candidates.

With our team of skilled experts and cutting-edge computational techniques, we propel drug development forward, accelerating timelines and optimizing outcomes. By seamlessly integrating data-driven methodologies, we revolutionize the efficiency of the entire process. Trust in our expertise to take the drug discovery journey to new heights of success.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024